 Koninklijke Philips NV NYSE: PHG reported third-quarter sales declined by 5.8 year-over-year to 4.16 billion, and a 7.6 comparable sales decline due to headwinds caused by global supply chain challenges and Sleep Respiratory Care recall consequences. For the quarter, Comparable order intake increased by 47. 